REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults
Type 2 Diabetes (Adult Onset), Medication Adherence
About this trial
This is an interventional treatment trial for Type 2 Diabetes (Adult Onset) focused on measuring Type 2 diabetes, Medication adherence, Mobile health, Latino adults
Eligibility Criteria
Inclusion Criteria: Type 2 diabetes mellitus Have current or prior (since 2018) HbA1c ≥8.0% Take at least one diabetes medication Receive care at MGH- affiliated primary care practices (≥2 visits in the past 3 years) ≥18 yrs Identify as Latino and/or Hispanic Speak and read in Spanish as preferred language Willing and able to provide informed consent Access to a mobile telephone with text messaging capability Suboptimal diabetes medication adherence, assessed using the first 2 items in the Adherence to Refill and Medication Scale (ARMS-d) questionnaire combined: "How frequently do you forget or decide to not take your diabetes medications?" Participants who answer sometimes, almost always, and/or always will be considered eligible for the study. Exclusion Criteria: Auditory limitations and/or inability to communicate orally Inability to receive, read, or send a text message (assessed by a trained research assistant)
Sites / Locations
- Massachusetts General Hospital Diabetes Research Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
REACH-Es
Enhanced treatment as usual (ETAU)
Participants in the REACH-Es arm will receive REACH-Es short message service (SMS), as follows: 1) Daily SMS (information related to diet, exercise, self-monitoring of blood glucose, their specific diabetes medication(s), and top 4 medication adherence barriers); 2) Daily two-way SMS (diabetes medication adherence question); 3) Weekly one-way SMS (participants receive weekly feedback on Sunday regarding how many of the last 7 days they took their medicine); 4) A SMS each time an HbA1c is collected with a link to a secure website that displays the result.
Participants will maintain care as usual (medication treatment and physician monitoring) in addition to a welcome SMS following enrollment, a SMS each time an HbA1c is collected with a link to a secure website that displays the result, and bi-monthly information on diabetes self-care education.